Tamiflu

Oseltamivir Phosphate capsules also market by Roche under brand name Tamiflu is anti-viral pill used in the prevention and treatment of influenza virus infection. The estimated sales for Oseltamivir Phosphate capsules is $382 million as per IMS December 2016 figures.

Zydus subsidiary receives USFDA nod to market Tamiflu drug

"Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the United States Food and Drug Administration (USFDA) to market oseltamivir phosphate capsules in strengths of 30 mg, 45 mg, and 75 mg," Cadila Healthcare said in a BSE filing.

Natco net profit surges five-fold to Rs 195 crore in Q3

The revenue and profit growth for the company during the quarter was driven predominantly by the sales of Oseltamivir product or generic Tamiflu in the US market and includes profit sharing from our marketing partner, Natco said in a statement.

Q3 results: Five trends to watch out from Indian drugmakers

Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounded annual growth rate (CAGR) over last 10 years

Natco Pharma rises 7% on USFDA final approval for Tamiflu

The company has received final approval of ANDA containing a paragraph IV certification filed with the US Food and Drug Administration (USFDA) for generic versions of Tamiflu oral capsules, 30 mg, 45 mg and 75 mg.

Natco Pharma gets ANDA nod for Tamiflu drugs generic version

"Natco and its marketing partner Alvogen are the first generic players to receive this approval," Natco said in a regulatory filing.

US SC denies review of Fed circuit ruling on Tamiflu: Natco

The Supreme Court has declined to review the Federal Circuit's decision. The case remains pending in the District of New Jersey where the validity of US Patent No 5,763,483 continues to be challenged, it added.

Natco Pharma soars 6% post US court order on Tamiflu patent

The US Supreme Court has declined a review of a federal circuit court ruling that favoured Natco Pharma in a patent infringement litigation over swine flu treatment drug Tamiflu.

Swine flu case detected in Gujarat

A confirmed case of swine flu (H1N1 influenza), first in Gujarat after the previous nation-wide outbreak of the epidemic, was reported in Rampura locality of Bakrol here. Ghanshyam Rathore (26) tested positive for swine flu, and his wife, mother and father were being given prophylactic treatment, District Health Officer S B Shah said.

Swine flu wonder cure under scanner

Billions of dollars were spent by countries across the world in stockpiling Tamiflu during the 2009 Swine Flu pandemic. India was one of 80 countries to stockpile the medication - buying 30 million doses.

Novartis sticks to 2011 goals as sales jump

Swiss drugmaker Novartis AG is sticking to its 2011 outlook after posting stronger-than-expected first-quarter sales on the back of robust demand for its newest products.

Gilead, Roche's suit on expected lines: Natco Pharma

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma said," In a patently challenged issue, the innovator is bound to protect his rights and this can be done only through the mechanism of suing.There is nothing extra-ordinary about it."

Natco Pharma challenges patent on Tamiflu

Natco Pharma has challenged a patent on Tamiflu (Oseltamivir Phosphate)—a drug used in the treatment of bird and swine-flu infections, reports the PTI.